Immuron (IMRN) Asset Writedowns and Impairment (2020 - 2023)

Immuron (IMRN) posted quarterly Asset Writedowns and Impairment of $13496.7 for Q2 2023, up 116.95% year-on-year from $6221.1 in Q2 2022, and up 116.95% on a QoQ basis from $6221.1 in Q2 2022.

Immuron (IMRN) Asset Writedowns and Impairment (2020 - 2023) Analysis & Trends

Immuron (IMRN) has reported Asset Writedowns and Impairment for 4 consecutive years, with $13496.7 the latest figure, recorded in Q2 2023.

  • Quarterly Asset Writedowns and Impairment rose 116.95% year-over-year to $13496.7 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$4326.3 (changed N/A YoY) and the FY2023 annual result came in at $13496.7, up 116.95% from the prior year.
  • Asset Writedowns and Impairment climbed to $13496.7 in Q2 2023 per IMRN's latest filing, from $6221.1 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for IMRN reached as high as $13496.7 in Q2 2023 and fell as low as -$21225.6 in Q2 2021.
  • A 4-year average of -$1081.6 and a median of $1701.3 in 2020 frame the typical range for Asset Writedowns and Impairment.
  • Annual changes were most pronounced in 2021 — Asset Writedowns and Impairment slumped 653.07% — and 2022, when it surged 129.31%.
  • Year by year, Asset Writedowns and Impairment stood at -$2818.5 in 2020, then sank by 653.07% to -$21225.6 in 2021, then jumped by 129.31% to $6221.1 in 2022, then jumped by 116.95% to $13496.7 in 2023.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $13496.7, $6221.1, and -$21225.6 for Q2 2023, Q2 2022, and Q2 2021 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,725.60 Bn 68,725.31 Bn -
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 472.73 Bn 467.94 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.52 Bn 116.27 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.74 Bn 60.99 Bn 3.31 Bn
7 Belite Bio 63.09 Bn 63.09 Bn -
8 Argenx Se 56.42 Bn 51.24 Bn 1.41 Bn
9 Revolution Medicines 37.76 Bn 37.76 Bn -
10 Immuron 258.65 Mn -28.05 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2023 13,496.66
Jun 30, 2023 13,496.66
Jun 30, 2022 6,221.13
Jun 30, 2022 6,221.13
Jun 30, 2021 -21,225.58
Jun 30, 2021 -21,225.58
Jun 30, 2020 -2,818.54
Jun 30, 2020 -2,818.54